Skip to main content

Closed

EBS: Emergent BioSolutions Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Operating margin10.5%

ROIC-14.9%

Financially safe

Stretched

Debt / equity1.10×

Interest coverage1.3×

Current ratio4.29×

Emergent BioSolutions Inc.

EBSNew York Stock Exchange·USD·Closed

Emergent BioSolutions Inc.

EBSNew York Stock Exchange·USD·Closed

$7.22

−0.55%

$7.22

−$0.04 (0.55%)

52W Range

19thpctl

Volume

0.45×avg

Mkt Cap

372.53MUSD

P/E

-42.5TTM

Div Yield

–ann

52W Range

19thpctl

Volume

0.45×avg

Market Cap

372.53MUSD

P/E Ratio

-42.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings